• レポートコード:MRC2110B001 • 出版社/出版日:Persistence Market Research / 2021年10月5日 • レポート形態:英文、PDF、245ページ • 納品方法:Eメール • 産業分類:医療 |
Individual User | ¥725,200 (USD4,900) | ▷ お問い合わせ |
Multi User | ¥1,124,800 (USD7,600) | ▷ お問い合わせ |
Corporate User | ¥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートでは、ノロウイルス診断の世界市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、新型コロナウイルス感染症の危機分析、主要成功要因、需要分析・予測、価格分析・予測、製品別(迅速検査キット、PCRキット、ELISAベースキット)分析、エンドユーザー別(病院、診断研究所、研究機関、バイオ製薬会社)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・市場背景 ・新型コロナウイルス感染症の危機分析 ・主要成功要因 ・需要分析・予測 ・価格分析・予測 ・ノロウイルス診断の世界市場規模:製品別(迅速検査キット、PCRキット、ELISAベースキット) ・ノロウイルス診断の世界市場規模:エンドユーザー別(病院、診断研究所、研究機関、バイオ製薬会社) ・ノロウイルス診断の世界市場規模:地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Norovirus Diagnostics Market – Scope of Report
The latest publication by Persistence Market Research on the global norovirus diagnostics market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market.
The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for norovirus diagnostics products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the norovirus diagnostics market. The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the norovirus diagnostics market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the norovirus diagnostics market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the norovirus diagnostics market offers information divided into 3 important segments – product, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
[Product]
Rapid Test Kits
PCR Kits
ELISA-based kits
[End User]
Hospitals
Diagnostics Labs
Clinics
[Region]
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Latest Market Consolidation Activities
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Growth Outlook
4.1.2. Global Healthcare Expenditure Outlook
4.1.3. Parent Market Outlook
4.2. Forecast Factors – Relevance & Impact
4.2.1. Rising prevalence of Norovirus
4.2.2. Increasing Demand for Rapid Testing
4.2.3. Technological Advancement
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Trends
4.3.4. Opportunity Analysis
5. COVID19 Crisis Analysis
5.1. Current COVID19 Probable Future Impact
5.2. Current GDP Projection and Probable Impact
5.3. COVID19 and Impact Analysis
5.3.1. Revenue by Product
5.3.2. Revenue by End User
5.3.3. Revenue By Region
5.4. Recovery Scenario – Short term, Midterm and Long Term Impact
6. Key Success Factors
6.1. Adoption / Usage Analysis
6.2. New product launches
6.3. Key regulations
6.4. Key Products USP Analysis
6.5. PESTLE Analysis
6.6. Porters Analysis
6.7. Value Chain analysis
6.8. Key Manufacturers Promotional Strategies Strategic
7. Global Norovirus Diagnostics Market Demand (in Volume ‘000 Units) Analysis 2016-2020 and Forecast, 2021–2031
7.1. Historical Market Volume (‘000 Units) Analysis, 2016-2020
7.2. Current and Future Market Volume (‘000 Units) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Norovirus Diagnostics Market- Pricing Analysis
8.1. Regional Pricing Analysis, By Product
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
9. Global Norovirus Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
9.2. Current and Future Market Value (In Value or Size in US$ Mn) Projections, 2021-2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend By Product, 2016-2020
10.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units)Trend Analysis and Forecast By Product, 2021-2031
10.3.1. Rapid test kits
10.3.2. PCR kits
10.3.3. ELISA based kits
10.4. Market Attractiveness Analysis By Product
11. Global Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (In Value or Size in US$ Mn) Trend By End User, 2016-2020
11.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis and Forecast By End User , 2021-2031
11.3.1. Hospitals
11.3.2. Diagnostic Laboratories
11.3.3. Research Institutes
11.3.4. Biopharmaceutical Companies.
11.4. Market Attractiveness Analysis By End User
12. Global Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, by Region
12.1. Introduction
12.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Analysis By Region, 2016 – 2020
12.3. Current Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Analysis and Forecast By Region, 2021 – 2031
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031
13.1. Introduction
13.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2016-2020
13.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis Forecast By Market Taxonomy, 2021-2031
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants – Intensity Mapping
13.6. Drivers and Restraints – Impact Analysis
14. Latin America Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2016 – 2020
14.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis Forecast By Market Taxonomy, 2021-2031
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants – Intensity Mapping
14.6. Drivers and Restraints – Impact Analysis
15. Europe Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2016-2020
15.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis Forecast By Market Taxonomy 2021-2031
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants – Intensity Mapping
15.6. Drivers and Restraints – Impact Analysis
16. South Asia Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2016-2020
16.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy 2021-2031
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants – Intensity Mapping
16.6. Drivers and Restraints – Impact Analysis
17. East Asia Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2016-2020
17.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2021-2031
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants – Intensity Mapping
17.6. Drivers and Restraints – Impact Analysis
18. Oceania Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2016-2020
18.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants – Intensity Mapping
18.6. Drivers and Restraints – Impact Analysis
19. Middle East and Africa Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031
19.1. Introduction
19.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2016-2020
19.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2021-2031
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. South Africa
19.3.1.4. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants – Intensity Mapping
19.6. Drivers and Restraints – Impact Analysis
20. Key Countries Norovirus Diagnostics Market Analysis 2021 & 2031
20.1. U.S. Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.1.1. By Product
20.1.2. By End User
20.2. Canada Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.2.1. By Product
20.2.2. By End User
20.3. Brazil Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.3.1. By Product
20.3.2. By End User
20.4. Mexico Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.4.1. By Product
20.4.2. By End User
20.5. Argentina Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.5.1. By Product
20.5.2. By End User
20.6. U.K. Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.6.1. By Product
20.6.2. By End User
20.7. Germany Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.7.1. By Product
20.7.2. By End User
20.8. France Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.8.1. By Product
20.8.2. By End User
20.9. Italy Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.9.1. By Product
20.9.2. By End User
20.10. Spain Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.10.1. By Product
20.10.2. By End User
20.11. BENELUX Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.11.1. By Product
20.11.2. By End User
20.12. Russia Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.12.1. By Product
20.12.2. By End User
20.13. India Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.13.1. By Product
20.13.2. By End User
20.14. ASEAN Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.14.1. By Product
20.14.2. By End User
20.15. Japan Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.15.1. By Product
20.15.2. By End User
20.16. China Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.16.1. By Product
20.16.2. By End User
20.17. South Korea Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.17.1. By Product
20.17.2. By End User
20.18. Australia Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.18.1. By Product
20.18.2. By End User
20.19. New Zealand Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.19.1. By Product
20.19.2. By End User
20.20. GCC Countries Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.20.1. By Product
20.20.2. By End User
20.21. Turkey Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031
20.21.1. By Product
20.21.2. By End User
20.22. South Africa Norovirus Diagnostics Market Value (US$) and Analysis, 2021 & 2031
20.22.1. By Product
20.22.2. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Concentration
21.3. Market Share Analysis of Top Players
21.4. Market Presence Analysis
21.4.1.1. Regional footprint of Players
21.4.1.2. Method foot print by Players
21.4.1.3. Channel Foot Print by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Abbott
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Profitability by Market Segments (Product/End User/Region)
22.3.1.4. Sales Footprint
22.3.1.5. Strategy Overview
22.3.1.5.1. Marketing Strategy
22.3.1.5.2. Product Strategy
22.3.1.5.3. End User Strategy
22.3.2. R-Biopharm AG
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Profitability by Market Segments (Product/End User/Region)
22.3.2.4. Sales Footprint
22.3.2.5. Strategy Overview
22.3.2.5.1. Marketing Strategy
22.3.2.5.2. Product Strategy
22.3.2.5.3. End User Strategy
22.3.3. Cepheid
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Profitability by Market Segments (Product/End User/Region)
22.3.3.4. Sales Footprint
22.3.3.5. Strategy Overview
22.3.3.5.1. Marketing Strategy
22.3.3.5.2. Product Strategy
22.3.3.5.3. End User Strategy
22.3.4. Luminex Corporation
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Profitability by Market Segments (Product/End User/Region)
22.3.4.4. Sales Footprint
22.3.4.5. Strategy Overview
22.3.4.5.1. Marketing Strategy
22.3.4.5.2. Product Strategy
22.3.4.5.3. End User Strategy
22.3.5. Meridian Bioscience
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Profitability by Market Segments (Product/End User/Region)
22.3.5.4. Sales Footprint
22.3.5.5. Strategy Overview
22.3.5.5.1. Marketing Strategy
22.3.5.5.2. Product Strategy
22.3.5.5.3. End User Strategy
22.3.6. ELITechGroup
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Profitability by Market Segments (Product/End User/Region)
22.3.6.4. Sales Footprint
22.3.6.5. Strategy Overview
22.3.6.5.1. Marketing Strategy
22.3.6.5.2. Product Strategy
22.3.6.5.3. End User Strategy
22.3.7. Biomérieux SA
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Profitability by Market Segments (Product/End User/Region)
22.3.7.4. Sales Footprint
22.3.7.5. Strategy Overview
22.3.7.5.1. Marketing Strategy
22.3.7.5.2. Product Strategy
22.3.7.5.3. End User Strategy
22.3.8. CerTest Biotec S.L.
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Profitability by Market Segments (Product/End User/Region)
22.3.8.4. Sales Footprint
22.3.8.5. Strategy Overview
22.3.8.5.1. Marketing Strategy
22.3.8.5.2. Product Strategy
22.3.8.5.3. End User Strategy
22.3.9. Elisabeth Pharmacon, Spol. S Ro
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Profitability by Market Segments (Product/End User/Region)
22.3.9.4. Sales Footprint
22.3.9.5. Strategy Overview
22.3.9.5.1. Marketing Strategy
22.3.9.5.2. Product Strategy
22.3.9.5.3. End User Strategy
22.3.10. Qiagen
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Profitability by Market Segments (Product/End User/Region)
22.3.10.4. Sales Footprint
22.3.10.5. Strategy Overview
22.3.10.5.1. Marketing Strategy
22.3.10.5.2. Product Strategy
22.3.10.5.3. End User Strategy
22.3.11. Altona Diagnostics GmbH
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Profitability by Market Segments (Product/End User/Region)
22.3.11.4. Sales Footprint
22.3.11.5. Strategy Overview
22.3.11.5.1. Marketing Strategy
22.3.11.5.2. Product Strategy
22.3.11.5.3. End User Strategy
22.3.12. Eiken Chemical Co.
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Profitability by Market Segments (Product/End User/Region)
22.3.12.4. Sales Footprint
22.3.12.5. Strategy Overview
22.3.12.5.1. Marketing Strategy
22.3.12.5.2. Product Strategy
22.3.12.5.3. End User Strategy
23. Assumptions and Acronyms Used
24. Research Methodology